For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Assessment and Management of Cancer-related Fatigue in Adults
T. Ekman,Victoria Mock,Rn,Gaston-Johansson Drmedsc,Mrs Karin Ahlberg,K. Ahlberg,F. Gaston‐Johansson
Abstract:REVIEW 70–100% of patients being treated for cancer are affected by cancer-related fatigue, which can be more distressing and disruptive to daily activities than the pain associated with the disease. 1–4 However, individuals are often reluctant to report fatigue, and cancer-care providers frequently do not screen for it because they are uncertain about how to treat the condition. 3 Evidence suggests that high degrees of fatigue during treatment can lead to significant reductions in physical functioning and quality of life, 5–8 yet its causes remain poorly understood. 9 We detail the prevalence and possible causes of fatigue, and critically assess methods for its assessment and management. The symptoms, as well as the distress associated with, and consequences of, cancer-related fatigue are also discussed. Finally, we identify what further research is needed. Definition Cancer-related fatigue, defined by the National Comprehensive Cancer Network (NCCN) as " a persistent, subjective sense of tiredness related to cancer or cancer treatment that interferes with usual functioning " , 10,11 can be described in terms of perceived energy, mental capacity, and psychological status. 12,13 It arises over a continuum, ranging from tiredness to exhaustion. But, by contrast with the tiredness sometimes felt by a healthy individual, cancer-related fatigue is perceived as being of greater magnitude, disproportionate to activity or exertion, and not completely relieved by rest, leaving the patient with an overwhelming and sustained sense of exhaustion. 14 Fatigue is an umbrella term used to describe various sensations or feelings, and a variety of expressions of reduced capacity at physical, mental, emotional, or social levels. related to indicators of tiredness, such as reduced energy expenditure, sleep disturbance, attention deficits, decreased endurance, and weakness, is unclear. 16 Incidence Fatigue is the most prevalent symptom of individuals with cancer who receive radiation therapy, cytotoxic chemotherapy, or biological response modifiers. 7,17–19 In one study, 20 75% of patients with various solid tumours (in which 48 of 95 had metastatic disease) had a significantly increased fatigue score by comparison with a matched control population. Furthermore, individuals who survive cancer report fatigue as a problem months to years after treatment ends. 21 In a survey of 1957 survivors of breast cancer, for example, a third reported severe and persistent fatigue 3 years after diagnosis. 22 The patient's perspective In healthy individuals, fatigue generally serves as a protective or pleasant response to physical or psychological stress. For patients with a chronic disease, …
Medicine